文献速递浆细胞疾病

具有临床意义的单克隆丙种球蛋白病:一个具有治疗意义的新概念

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications.
PubMed 文献 · Blood · 2018-07-16

本文提出「具有临床意义的单克隆丙种球蛋白病(MGCS)」新概念,指小而静止的B细胞克隆虽无需本身治疗,却因单克隆免疫球蛋白毒性或其他机制导致潜在严重器官损害。文章按组织损伤机制对MGCS进行分类,阐述其诊断与治疗原则,强调有效控制B细胞克隆通常可改善器官功能。

要点

  • MGCS指静止的小B细胞克隆伴潜在严重器官损害,需快速特异性干预以保护器官功能。
  • MGCS按组织损伤机制分类,诊断与治疗常具挑战性,需多学科协作。
  • 有效控制B细胞克隆通常带来器官改善,目前主要依赖化疗及抗B细胞/浆细胞药物。

核心结论

  • 提出具有临床意义的单克隆丙种球蛋白病(MGCS)概念,以改善对小B细胞克隆相关疾病的认识与管理。
  • 有效控制 underlying B细胞克隆通常可带来器官改善。

研究设计与样本

  • 本文为概念提出与综述性报告,按组织损伤机制对MGCS进行分类并描述管理原则。

主要发现

  • MGCS涉及小而静止、本身无需治疗的B细胞克隆,但因单克隆免疫球蛋白毒性或其他机制导致潜在严重器官损害。
  • 这类疾病日益多见但仍认识不足且常治疗不充分,尽管常需快速特异性干预以保护受累器官功能。
  • MGCS诊断与治疗在临床实践中常具挑战性,需要多学科协作。

临床怎么用

  • 有效控制 underlying B细胞克隆通常可带来器官改善。
  • 目前主要依赖化疗及其他抗B细胞/浆细胞药物,应旨在快速产生最佳血液学反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monoclonal gammopathy is a common condition, particularly in the elderly. It can indicate symptomatic multiple myeloma or another overt malignant lymphoid disorder requiring immediate chemotherapy. More frequently, it results from a small and/or quiescent secreting B-cell clone, is completely asymptomatic, and requires regular monitoring only, defining a monoclonal gammopathy of unknown significance (MGUS). Sometimes, although quiescent and not requiring any treatment per se, the clone is associated with potentially severe organ damage due to the toxicity of the monoclonal immunoglobulin or to other mechanisms. The latter situation is increasingly observed but still poorly recognized and frequently undertreated, although it often requires rapid specific intervention to preserve involved organ function. To improve early recognition and management of these small B-cell clone-related disorders, we propose to introduce the concept of monoclonal gammopathy of clinical significance (MGCS). This report identifies the spectrum of MGCSs that are classified according to mechanisms of tissue injury. It highlights the diversity of these disorders for which diagnosis and treatment are often challenging in clinical practice and require a multidisciplinary approach. Principles of management, including main diagnostic and therapeutic procedures, are also described. Importantly, efficient control of the underlying B-cell clone usually results in organ improvement. Currently, it relies mainly on chemotherapy and other anti-B-cell/plasma cell agents, which should aim at rapidly producing the best hematological response.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Fermand JP, Bridoux F, Dispenzieri A, et al. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood. 2018. PMID: 30012636. doi:10.1182/blood-2018-04-839480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。